Frederick G. Vogt - Interim CEO & General Counsel, Director at IOVANCE BIOTHERAPEUTICS, INC.

Insider Transactions and Holdings

Entity Type
Individual
Role
Interim CEO & General Counsel, Director
Issuer Symbol
IOVA on Nasdaq
All Insider Reports
All Insider Reports

Frederick G. Vogt - trading volume in the past year for IOVANCE BIOTHERAPEUTICS, INC.

Holdings reported by Frederick G. Vogt for IOVANCE BIOTHERAPEUTICS, INC.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 529,538 $1,376,798 $2.60 05 Mar 2026 Direct
Restricted Stock Units 125,007 $757,500 $4.04 05 Mar 2026 Direct Common stock

Transactions reported by Frederick G. Vogt for IOVANCE BIOTHERAPEUTICS, INC.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.